Walleye Trading’s Biohaven BHVN Stock Holding History

Walleye Trading’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$350K	Sell	41,400 -15,700	-27%	-$172K	﹤0.01%	2794
2025 Q4	$645K	Buy	57,100 +42,500	+291%	+$527K	﹤0.01%	2644
2025 Q3	$219K	Buy	14,600 +5,700	+64%	+$83K	﹤0.01%	3310
2025 Q2	$126K	Buy	+8,900	New	+$159K	﹤0.01%	3487
2024 Q1	–	Sell	-7,100	Closed	-$304K	–	4772
2023 Q4	$304K	Sell	7,100 -13,000	-65%	-$404K	﹤0.01%	3485
2023 Q3	$523K	Buy	20,100 +18,200	+958%	+$378K	﹤0.01%	2927
2023 Q2	$45.4K	Sell	1,900 -12,400	-87%	-$213K	﹤0.01%	3983
2023 Q1	$195K	Sell	14,300 -101,000	-88%	-$1.61M	﹤0.01%	3521
2022 Q4	$1.6M	Buy	+115,300	New	+$1.63M	﹤0.01%	1860

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's BHVN Position: Q1 2026 in Review

Walleye Trading reduced its Biohaven (BHVN) stake by 69% in Q1 2026, selling an estimated $103K and leaving 4,153 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

Walleye Trading first reported a position in BHVN in Q1 2023 and has held it in 7 quarters since. The position peaked at $872K in Q2 2023. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Walleye Trading held 4,153 shares of Biohaven worth $35.1K as of Q1 2026.
Walleye Trading sold 9,400 Biohaven shares in Q1 2026, an estimated $103K.
Biohaven made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3761 holding.
Walleye Trading first reported a position in Biohaven in Q1 2023 and has held it in 7 quarters since.
Walleye Trading's Biohaven position peaked at $872K in Q2 2023.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.